These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 812914)

  • 21. Association of activated properdin with complexes of properdin with C3.
    Whiteman LY; Purkall DB; Ruddy S
    J Immunol; 1991 Aug; 147(4):1344-51. PubMed ID: 1869827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysis of Neisseria gonorrhoeae initiated by binding of normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strain-specific, properdin-binding-dependent alternative complement pathway activation.
    Griffiss JM; Jarvis GA; O'Brien JP; Eads MM; Schneider H
    J Immunol; 1991 Jul; 147(1):298-305. PubMed ID: 1711080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
    Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
    J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of zinc on lysis of sheep erythrocytes by guinea pig C4-deficient serum.
    Evans BD; Amiraian K
    Mol Immunol; 1987 Dec; 24(12):1345-50. PubMed ID: 3431554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effect of various antisera and cobra venom factor on inflammatory reactions in guinea-pig skin. I. Non-specific inflammation due to the intradermal injection of turpentine.
    Lewis E; Turk JL
    J Pathol; 1975 Feb; 115(2):97-109. PubMed ID: 1080193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of Guinea pig properidin.
    Nicholson A; Austen KF
    J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.
    Stossel TP; Alper CA; Rosen FS
    J Exp Med; 1973 Mar; 137(3):690-705. PubMed ID: 4631990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of factor B and C3 in guinea pig serum by zymosan or by activated properdin depends on the presence of factor D.
    Brade V; Bentley C; Kossorotow A; Bitter-Suermann D
    Monogr Allergy; 1977; 12():83-5. PubMed ID: 917024
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on rat complement. I. Immune adherence and immune hemolysis activities of rat serum.
    Sakamoto M
    Jpn J Exp Med; 1975 Jun; 45(3):183-9. PubMed ID: 1177359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-independent activation of the alternative complement pathway in human serum by parasitic cells.
    Kierszenbaum F; Weinman D
    Immunology; 1977 Feb; 32(2):245-9. PubMed ID: 844897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the alternative complement pathway by Trichomonas vaginalis.
    Gillin FD; Sher A
    Infect Immun; 1981 Oct; 34(1):268-73. PubMed ID: 6795124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
    Nakanishi K; Zbar B; Borsos T; Glenn G
    Cancer Res; 1986 Aug; 46(8):3886-90. PubMed ID: 3089581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.